Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_assertion type Assertion NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_head.
- NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_assertion description "[p16 (540C/580T) has emerged as a major risk haplotype (P=0.033, OR=1.47, 95% CI=1.05-2.07) whereas p16 (540G/580T) as a chief protective haplotype (P=0.014, OR=0.39, 95% CI=0.18-0.83) for the development of cervical cancer among Indian women.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_provenance.
- NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_assertion evidence source_evidence_literature NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_provenance.
- NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_assertion SIO_000772 21567202 NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_provenance.
- NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_assertion wasDerivedFrom befree-20140225 NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_provenance.
- NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_assertion wasGeneratedBy ECO_0000203 NP264430.RAO3qYIHwF6rlROJo4V_Jw9Pi_E2_bAsTsl81a5euPpZM130_provenance.